All sponsors

Swedish Orphan Biovitrum

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS6
PHASE 3 / 2-35
RECRUITING2
READOUTS ≤12 MONTHS2
Open Swedish Orphan Biovitrum on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
Anakinra
NCT05814159
P3Active, not recruitingStill's Disease, Juvenile Onset; Still's Disease, Adult-Onset152025-12-10 (+24 mo)
PACIFICA
NCT03165734
P3Active, not recruitingPrimary Myelofibrosis; Post-polycythemia Vera Myelofibrosis4072026-10-05 (+94 mo)
Pacritinib
NCT06782373
P2RecruitingVEXAS; VEXAS Syndrome1562026-12-30 (-7 mo)
LIBERTY
NCT06716814
P3Active, not recruitingHaemophilia A (Moderate or Severe)892027-03 (+7 mo)
Avatrombopag 20 mg Oral Tablet
NCT07786922
P2/3Not yet recruitingAplastic Anemia262028-06-30
PRESERVE
NCT07898774
P3RecruitingC3 Glomerulopathy (C3G), Primary Immune-Complex Membranoproliferative Glomerulonephritis (IC-MPGN); Recurrent Glomerular Disease After Kidney Transplantation302031-01-17